RecruitingNot ApplicableNCT06724185
Effects of LP28 on Immunity Enhancement in the Elderly
Sponsor
Synbio Tech Inc.
Enrollment
100 participants
Start Date
Jul 9, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
Due to the increasing attention on aging-related health issues, this study focuses on the elderly population as participants. The aim is to investigate whether supplementation with Lactobacillus plantarum LP28 can effectively enhance immunity, reduce the frequency and severity of common cold infections, and ultimately promote overall health in the elderly.
Eligibility
Min Age: 50 YearsMax Age: 75 Years
Inclusion Criteria1
- Those who had symptoms of common cold or tonsillitis at least twice in the past year.
Exclusion Criteria5
- People who have liver, kidney, immune, or neoplastic diseases diagnosed by doctor.
- People with mental illnesses such as schizophrenia or depression.
- People who have allergic rhinitis.
- People who have a current condition of drug or alcohol dependence.
- Any person is deemed inappropriate by the researcher for the clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIETARY_SUPPLEMENTLP28 capsule
LP28 capsule : 5.0×10\^9 CFU/capsule
DIETARY_SUPPLEMENTPlacebo Capsule
Maltodextrin
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06724185
Related Trials
Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer
NCT067689315 locations
Efficacy of Symprove Probiotics in Coeliac Disease
NCT073601061 location
Understanding Immunity to the Flu Vaccine in COVID-19 Patients
NCT045795881 location
Probiotic-Based Versus Ethyl Lauroyl Arginate-Containing Mouthwashes on Streptococcus Mutans Counts, Dental Plaque Accumulation, and Salivary pH in a Group of Egyptian School Children
NCT073568691 location
Effects of Bacillus Coagulans SNZ 1969 on Immune Health in Healthy School-aged Children
NCT073417501 location